10-Q Filing

NOVO INTEGRATED SCIENCES, INC. CIK: 1138978 Q2 2017

Filing Information

Form Type	10-Q
Accession Number	`0001493152-17-008127`
Period End Date	20170531
Filing Date	20170724
Fiscal Year	2017
Fiscal Period	Q2
XBRL Instance	nvos-20170531.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 74 Income Statement 84 Cash Flow Statement 54 Stockholders Equity 14

Balance Sheet 74 line items

Line Item	Tag	Value	Unit	Period
Convertible preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Convertible preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Convertible preferred stock, shares authorized	`PreferredStockSharesAuthorized`	1.00M	shares	Point-in-time
Convertible preferred stock, shares authorized	`PreferredStockSharesAuthorized`	1.00M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$110.31K	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$68.08K	USD	Point-in-time
Convertible preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$306.56K	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$1.67M	USD	Point-in-time
Convertible preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Convertible preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Convertible preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Accounts receivable, net	`AccountsReceivableNetCurrent`	$785.78K	USD	Point-in-time
Accounts receivable, net	`AccountsReceivableNetCurrent`	$854.92K	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Other receivables	`OtherReceivablesNetCurrent`	$1.08M	USD	Point-in-time
Other receivables	`OtherReceivablesNetCurrent`	$735.33K	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	499.00M	shares	Point-in-time
Due from related parties	`DueFromRelatedPartiesCurrent`	$951.71K	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	499.00M	shares	Point-in-time
Due from related parties	`DueFromRelatedPartiesCurrent`	$784.83K	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$156.22K	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$161.22K	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	167.80M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	198.92M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$2.57M	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	198.92M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	167.80M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$4.73M	USD	Point-in-time
Furniture and equipment, net	`PropertyPlantAndEquipmentNet`	$318.72K	USD	Point-in-time
Furniture and equipment, net	`PropertyPlantAndEquipmentNet`	$291.73K	USD	Point-in-time
Goodwill	`Goodwill`	-	USD	Point-in-time
Goodwill	`Goodwill`	$370.25K	USD	Point-in-time
TOTAL ASSETS	`Assets`	$5.39M	USD	Point-in-time
TOTAL ASSETS	`Assets`	$2.89M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$1.90M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$2.04M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$36.60K	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$235.42K	USD	Point-in-time
Accrued interest (principally to related parties)	`InterestPayableCurrent`	$1.04M	USD	Point-in-time
Accrued interest (principally to related parties)	`InterestPayableCurrent`	$832.77K	USD	Point-in-time
Due to related parties	`DueToRelatedPartiesCurrent`	$1.84M	USD	Point-in-time
Due to related parties	`DueToRelatedPartiesCurrent`	$1.82M	USD	Point-in-time
Notes payable	`NotesPayableCurrent`	$34.24K	USD	Point-in-time
Notes payable	`NotesPayableCurrent`	$147.52K	USD	Point-in-time
Debentures, related parties	`SecuredDebtCurrent`	$4.88M	USD	Point-in-time
Debentures, related parties	`SecuredDebtCurrent`	$4.74M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$9.57M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$9.97M	USD	Point-in-time
Notes payable, net of current portion	`LongTermNotesPayable`	$372.00K	USD	Point-in-time
Notes payable, net of current portion	`LongTermNotesPayable`	$11.58K	USD	Point-in-time
TOTAL LIABILITIES	`Liabilities`	$9.98M	USD	Point-in-time
TOTAL LIABILITIES	`Liabilities`	$9.94M	USD	Point-in-time
Commitments and contingencies (Note 10)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies (Note 10)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Convertible Preferred stock; $0.001 par value; 1,000,000 shares authorized; 0 and 0 shares issued and outstanding at May 31, 2017 and August 31, 2016	`PreferredStockValue`	-	USD	Point-in-time
Convertible Preferred stock; $0.001 par value; 1,000,000 shares authorized; 0 and 0 shares issued and outstanding at May 31, 2017 and August 31, 2016	`PreferredStockValue`	-	USD	Point-in-time
Common stock; $0.001par value; 499,000,000 shares authorized; 198,917,213 and 167,797,406 shares issued and outstanding at May 31, 2017 and August 31, 2016	`CommonStockValue`	$92.00	USD	Point-in-time
Common stock; $0.001par value; 499,000,000 shares authorized; 198,917,213 and 167,797,406 shares issued and outstanding at May 31, 2017 and August 31, 2016	`CommonStockValue`	$198.92K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$2.52M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	-	USD	Point-in-time
Other comprehensive income	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$1.56M	USD	Point-in-time
Other comprehensive income	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$1.28M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-8.81M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-8.35M	USD	Point-in-time
Total Novo Integrated Sciences, Inc. stockholders' deficit	`StockholdersEquity`	$-4.53M	USD	Point-in-time
Total Novo Integrated Sciences, Inc. stockholders' deficit	`StockholdersEquity`	$-7.08M	USD	Point-in-time
Noncontrolling interest	`MinorityInterest`	$-17.95K	USD	Point-in-time
Noncontrolling interest	`MinorityInterest`	$-12.67K	USD	Point-in-time
Total deficit	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-7.09M	USD	Point-in-time
Total deficit	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-4.55M	USD	Point-in-time
TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT	`LiabilitiesAndStockholdersEquity`	$5.39M	USD	Point-in-time
TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT	`LiabilitiesAndStockholdersEquity`	$2.89M	USD	Point-in-time

Income Statement 84 line items

Line Item	Tag	Value	Unit	Period
Revenues	`Revenues`	$1.89M	USD	1 Quarter
Revenues	`Revenues`	$2.09M	USD	1 Quarter
Revenues	`Revenues`	$5.74M	USD	3 Qtrs
Revenues	`Revenues`	$5.34M	USD	3 Qtrs
Cost of revenues	`CostOfRevenue`	$3.48M	USD	3 Qtrs
Cost of revenues	`CostOfRevenue`	$1.21M	USD	1 Quarter
Cost of revenues	`CostOfRevenue`	$1.38M	USD	1 Quarter
Cost of revenues	`CostOfRevenue`	$3.73M	USD	3 Qtrs
Gross profit	`GrossProfit`	$676.29K	USD	1 Quarter
Gross profit	`GrossProfit`	$1.87M	USD	3 Qtrs
Gross profit	`GrossProfit`	$2.01M	USD	3 Qtrs
Gross profit	`GrossProfit`	$713.06K	USD	1 Quarter
Selling expenses	`SellingExpense`	$3.99K	USD	1 Quarter
Selling expenses	`SellingExpense`	$16.37K	USD	1 Quarter
Selling expenses	`SellingExpense`	$34.93K	USD	3 Qtrs
Selling expenses	`SellingExpense`	$20.95K	USD	3 Qtrs
General and administrative expenses	`GeneralAndAdministrativeExpense`	$1.74M	USD	3 Qtrs
General and administrative expenses	`GeneralAndAdministrativeExpense`	$957.56K	USD	1 Quarter
General and administrative expenses	`GeneralAndAdministrativeExpense`	$614.95K	USD	1 Quarter
General and administrative expenses	`GeneralAndAdministrativeExpense`	$2.13M	USD	3 Qtrs
Total operating expenses	`OperatingExpenses`	$1.76M	USD	3 Qtrs
Total operating expenses	`OperatingExpenses`	$618.94K	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$973.93K	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$2.16M	USD	3 Qtrs
Income (loss) from operations	`OperatingIncomeLoss`	$-260.87K	USD	1 Quarter
Income (loss) from operations	`OperatingIncomeLoss`	$-150.94K	USD	3 Qtrs
Income (loss) from operations	`OperatingIncomeLoss`	$57.35K	USD	1 Quarter
Income (loss) from operations	`OperatingIncomeLoss`	$107.66K	USD	3 Qtrs
Interest income	`InvestmentIncomeInterest`	$8.89K	USD	1 Quarter
Interest income	`InvestmentIncomeInterest`	$17.02K	USD	3 Qtrs
Interest income	`InvestmentIncomeInterest`	$30.88K	USD	3 Qtrs
Interest income	`InvestmentIncomeInterest`	$5.69K	USD	1 Quarter
Interest expense	`InterestExpense`	$131.42K	USD	1 Quarter
Interest expense	`InterestExpense`	$105.98K	USD	1 Quarter
Interest expense	`InterestExpense`	$337.69K	USD	3 Qtrs
Interest expense	`InterestExpense`	$388.60K	USD	3 Qtrs
Other expense	`OtherNonoperatingExpense`	-	USD	1 Quarter
Other expense	`OtherNonoperatingExpense`	-	USD	1 Quarter
Other expense	`OtherNonoperatingExpense`	-	USD	3 Qtrs
Other expense	`OtherNonoperatingExpense`	-	USD	3 Qtrs
Total other income (expense)	`NonoperatingIncomeExpense`	$-371.58K	USD	3 Qtrs
Total other income (expense)	`NonoperatingIncomeExpense`	$-97.09K	USD	1 Quarter
Total other income (expense)	`NonoperatingIncomeExpense`	$-306.81K	USD	3 Qtrs
Total other income (expense)	`NonoperatingIncomeExpense`	$-125.73K	USD	1 Quarter
Loss before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-457.75K	USD	3 Qtrs
Loss before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-357.96K	USD	1 Quarter
Loss before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-68.38K	USD	1 Quarter
Loss before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-263.92K	USD	3 Qtrs
Income tax expense	`IncomeTaxExpenseBenefit`	-	USD	1 Quarter
Income tax expense	`IncomeTaxExpenseBenefit`	-	USD	1 Quarter
Income tax expense	`IncomeTaxExpenseBenefit`	-	USD	3 Qtrs
Income tax expense	`IncomeTaxExpenseBenefit`	-	USD	3 Qtrs
Net loss	`ProfitLoss`	$-68.38K	USD	1 Quarter
Net loss	`ProfitLoss`	$-457.75K	USD	3 Qtrs
Net loss	`ProfitLoss`	$-357.96K	USD	1 Quarter
Net loss	`ProfitLoss`	$-263.92K	USD	3 Qtrs
Net loss attributed to noncontrolling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$-1.57K	USD	1 Quarter
Net loss attributed to noncontrolling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$-4.10K	USD	3 Qtrs
Net loss attributed to noncontrolling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$-5.71K	USD	3 Qtrs
Net loss attributed to noncontrolling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$-1.22K	USD	1 Quarter
Net loss attributed to Novo Integrated Sciences, Inc.	`NetIncomeLoss`	$-259.82K	USD	3 Qtrs
Net loss attributed to Novo Integrated Sciences, Inc.	`NetIncomeLoss`	$-452.03K	USD	3 Qtrs
Net loss attributed to Novo Integrated Sciences, Inc.	`NetIncomeLoss`	$-356.74K	USD	1 Quarter
Net loss attributed to Novo Integrated Sciences, Inc.	`NetIncomeLoss`	$-66.81K	USD	1 Quarter
Net loss	`ProfitLoss`	$-68.38K	USD	1 Quarter
Net loss	`ProfitLoss`	$-457.75K	USD	3 Qtrs
Net loss	`ProfitLoss`	$-357.96K	USD	1 Quarter
Net loss	`ProfitLoss`	$-263.92K	USD	3 Qtrs
Foreign currency translation gain (loss)	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax`	$281.68K	USD	3 Qtrs
Foreign currency translation gain (loss)	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax`	$-128.70K	USD	1 Quarter
Foreign currency translation gain (loss)	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax`	$214.79K	USD	1 Quarter
Foreign currency translation gain (loss)	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax`	$22.22K	USD	3 Qtrs
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-143.18K	USD	1 Quarter
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-176.06K	USD	3 Qtrs
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-197.07K	USD	1 Quarter
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-241.70K	USD	3 Qtrs
Weighted average common shares outstanding - basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	169.88M	shares	3 Qtrs
Weighted average common shares outstanding - basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	167.80M	shares	1 Quarter
Weighted average common shares outstanding - basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	173.97M	shares	1 Quarter
Weighted average common shares outstanding - basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	167.80M	shares	3 Qtrs
Net loss per common share - basic and diluted	`EarningsPerShareBasicAndDiluted`	-	USD	3 Qtrs
Net loss per common share - basic and diluted	`EarningsPerShareBasicAndDiluted`	-	USD	3 Qtrs
Net loss per common share - basic and diluted	`EarningsPerShareBasicAndDiluted`	-	USD	1 Quarter
Net loss per common share - basic and diluted	`EarningsPerShareBasicAndDiluted`	-	USD	1 Quarter

Cash Flow Statement 54 line items

Line Item	Tag	Value	Unit	Period
Net loss	`ProfitLoss`	$-68.38K	USD	1 Quarter
Net loss	`ProfitLoss`	$-457.75K	USD	3 Qtrs
Net loss	`ProfitLoss`	$-357.96K	USD	1 Quarter
Net loss	`ProfitLoss`	$-263.92K	USD	3 Qtrs
Depreciation	`Depreciation`	$46.87K	USD	3 Qtrs
Depreciation	`Depreciation`	$54.66K	USD	3 Qtrs
Fair value of vested stock options	`SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1`	-	USD	3 Qtrs
Fair value of vested stock options	`SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1`	$-197.92K	USD	3 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$92.59K	USD	3 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$-531.57K	USD	3 Qtrs
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$9.54K	USD	3 Qtrs
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-51.12K	USD	3 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$-89.25K	USD	3 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$-145.26K	USD	3 Qtrs
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$-194.88K	USD	3 Qtrs
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$-242.03K	USD	3 Qtrs
Accrued interest	`IncreaseDecreaseInInterestPayableNet`	$234.55K	USD	3 Qtrs
Accrued interest	`IncreaseDecreaseInInterestPayableNet`	$266.35K	USD	3 Qtrs
Net cash provided by (used in) operating activities	`NetCashProvidedByUsedInOperatingActivitiesContinuingOperations`	$-364.67K	USD	3 Qtrs
Net cash provided by (used in) operating activities	`NetCashProvidedByUsedInOperatingActivitiesContinuingOperations`	$252.50K	USD	3 Qtrs
Purchase of furniture and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$28.62K	USD	3 Qtrs
Purchase of furniture and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$35.62K	USD	3 Qtrs
Amounts loaned for other receivables	`PaymentsForProceedsFromLoansReceivable`	$375.45K	USD	3 Qtrs
Amounts loaned for other receivables	`PaymentsForProceedsFromLoansReceivable`	$404.35K	USD	3 Qtrs
Cash acquired in reverse merger transaction	`CashAcquiredFromAcquisition`	$12.25K	USD	3 Qtrs
Cash acquired in reverse merger transaction	`CashAcquiredFromAcquisition`	-	USD	3 Qtrs
Net cash provided by (used in) investing activities	`NetCashProvidedByUsedInInvestingActivitiesContinuingOperations`	$-439.97K	USD	3 Qtrs
Net cash provided by (used in) investing activities	`NetCashProvidedByUsedInInvestingActivitiesContinuingOperations`	$-391.82K	USD	3 Qtrs
Advances (repayments) to related parties	`ProceedsFromRepaymentsOfRelatedPartyDebt`	$-159.87K	USD	3 Qtrs
Advances (repayments) to related parties	`ProceedsFromRepaymentsOfRelatedPartyDebt`	$472.76K	USD	3 Qtrs
Proceeds from the sale of common stock	`ProceedsFromIssuanceOfCommonStock`	-	USD	3 Qtrs
Proceeds from the sale of common stock	`ProceedsFromIssuanceOfCommonStock`	$2.51M	USD	3 Qtrs
Payments on notes payable	`RepaymentsOfNotesPayable`	$48.04K	USD	3 Qtrs
Payments on notes payable	`RepaymentsOfNotesPayable`	$120.28K	USD	3 Qtrs
Net cash provided by (used in) financing activities	`NetCashProvidedByUsedInFinancingActivitiesContinuingOperations`	$2.23M	USD	3 Qtrs
Net cash provided by (used in) financing activities	`NetCashProvidedByUsedInFinancingActivitiesContinuingOperations`	$424.71K	USD	3 Qtrs
Effect of exchange rate changes on cash and equivalents	`EffectOfExchangeRateOnCashAndCashEquivalents`	$89.95K	USD	3 Qtrs
Effect of exchange rate changes on cash and equivalents	`EffectOfExchangeRateOnCashAndCashEquivalents`	$1.25K	USD	3 Qtrs
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$1.56M	USD	3 Qtrs
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$238.48K	USD	3 Qtrs
CASH AND CASH EQUIVALENTS, BEGINNING OF PERIOD	`CashAndCashEquivalentsAtCarryingValue`	$110.31K	USD	Point-in-time
CASH AND CASH EQUIVALENTS, BEGINNING OF PERIOD	`CashAndCashEquivalentsAtCarryingValue`	$68.08K	USD	Point-in-time
CASH AND CASH EQUIVALENTS, BEGINNING OF PERIOD	`CashAndCashEquivalentsAtCarryingValue`	$306.56K	USD	Point-in-time
CASH AND CASH EQUIVALENTS, BEGINNING OF PERIOD	`CashAndCashEquivalentsAtCarryingValue`	$1.67M	USD	Point-in-time
CASH AND CASH EQUIVALENTS, END OF PERIOD	`CashAndCashEquivalentsAtCarryingValue`	$110.31K	USD	Point-in-time
CASH AND CASH EQUIVALENTS, END OF PERIOD	`CashAndCashEquivalentsAtCarryingValue`	$68.08K	USD	Point-in-time
CASH AND CASH EQUIVALENTS, END OF PERIOD	`CashAndCashEquivalentsAtCarryingValue`	$306.56K	USD	Point-in-time
CASH AND CASH EQUIVALENTS, END OF PERIOD	`CashAndCashEquivalentsAtCarryingValue`	$1.67M	USD	Point-in-time
Interest	`InterestPaid`	$129.88K	USD	3 Qtrs
Interest	`InterestPaid`	$122.31K	USD	3 Qtrs
Income taxes	`IncomeTaxesPaidNet`	-	USD	3 Qtrs
Income taxes	`IncomeTaxesPaidNet`	-	USD	3 Qtrs
Note payable issued for purchase of assets	`NoncashOrPartNoncashAcquisitionDebtAssumed1`	$375.45K	USD	3 Qtrs
Note payable issued for purchase of assets	`NoncashOrPartNoncashAcquisitionDebtAssumed1`	-	USD	3 Qtrs

Stockholders Equity 14 line items

Line Item	Tag	Value	Unit	Period
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-7.09M	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-4.55M	USD	Point-in-time
Common stock issued in connection with reverse merger transaction	`StockIssuedDuringPeriodValueAcquisitions`	$6.90K	USD	3 Qtrs
Common stock issued in connection with reverse merger transaction, shares	`StockIssuedDuringPeriodSharesAcquisitions`	22.75M	shares	3 Qtrs
Common stock issued for cash	`StockIssuedDuringPeriodValueNewIssues`	$2.51M	USD	3 Qtrs
Common stock issued for cash, shares	`StockIssuedDuringPeriodSharesNewIssues`	8.37M	shares	3 Qtrs
Fair value of vested stock options	`AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition`	$197.92K	USD	3 Qtrs
Foreign currency translation gain	`OtherComprehensiveIncomeForeignCurrencyTranslationAdjustmentTaxPortionAttributableToNoncontrollingInterest`	$282.12K	USD	3 Qtrs
Net loss	`ProfitLoss`	$-68.38K	USD	1 Quarter
Net loss	`ProfitLoss`	$-457.75K	USD	3 Qtrs
Net loss	`ProfitLoss`	$-357.96K	USD	1 Quarter
Net loss	`ProfitLoss`	$-263.92K	USD	3 Qtrs
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-7.09M	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-4.55M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.